Schrodinger Inc (SDGR)

$22.17 -0.35 (-1.55%)
Market Cap 1.66B
Revenue (ttm) 207.54M
Net Income (ttm) -187.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -90.16%
Debt to Equity Ratio 0.00
Volume 1,152,900
Avg Vol 1,113,056
Day's Range N/A - N/A
Shares Out 73.61M
Stochastic %K 79%
Beta 1.74
Analysts Strong Sell
Price Target $26.36

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through...

Industry: Health Information Services
Sector: Healthcare
Phone: 212 295 5800
Address:
1540 Broadway, 24th Floor, New York, United States
scott52
scott52 Oct. 24 at 2:48 PM
$SDGR $22.65. Sheer madness. Maybe a pump on some phase 1 bullshit and a chance to go dump the long and go short at $27.50.
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 21 at 7:05 PM
$SDGR POS
1 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 21 at 4:45 PM
$SDGR Buy the dip!
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 20 at 10:43 PM
$SDGR Going long for $30+
0 · Reply
VitaEBella
VitaEBella Oct. 20 at 9:22 PM
$SDGR Mamma Mia! I should leave town more often...
0 · Reply
OrzzrO
OrzzrO Oct. 20 at 5:07 PM
$SDGR keep pumping, what’s the story?
1 · Reply
xyzvector
xyzvector Oct. 19 at 3:51 PM
$SDGR AI potential and beaten down stock price....looks interesting
0 · Reply
luckydirb
luckydirb Oct. 19 at 3:31 AM
$SDGR as a deeply dei-ed company now, I don't see how they can grow up.
0 · Reply
SaluteYourShorts
SaluteYourShorts Oct. 15 at 1:47 PM
$SDGR heating up again
1 · Reply
stockwatcherking
stockwatcherking Oct. 15 at 1:34 PM
$SDGR Under the radar AI biotech ticker. Long here. I believe AI will transform the entire biotech industry, and SDGR will be a leader. Long here and $XBI
1 · Reply
Latest News on SDGR
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Oct 22, 2025, 8:30 AM EDT - 6 days ago

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Oct 15, 2025, 8:30 AM EDT - 13 days ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 3:05 PM EDT - 7 weeks ago

Schrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 2 months ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 14, 2025, 7:00 AM EDT - 2 months ago

Schrödinger Announces Discontinuation of SGR-2921 Program

Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:20 PM EDT - 2 months ago

Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript

Schrödinger Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 2 months ago

Schrödinger Reports Second Quarter 2025 Financial Results

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Jul 25, 2025, 8:30 AM EDT - 3 months ago

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Jul 18, 2025, 10:25 AM EDT - 3 months ago

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

Jul 17, 2025, 8:00 AM EDT - 3 months ago

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Jun 27, 2025, 8:00 AM EDT - 4 months ago

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results

Jun 13, 2025, 1:02 PM EDT - 4 months ago

Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Jun 12, 2025, 7:00 AM EDT - 4 months ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Shareholders to Inquire about Securities Investigation

Jun 6, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Shareholders to Connect

Jun 5, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Schrödinger, Inc. (SDGR) And Encourages Shareholders to Reach Out

Jun 4, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Schrödinger, Inc. (SDGR) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Shareholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Stockholders to Inquire about Securities Investigation

Jun 2, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Investors to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Investors to Learn More About the Investigation

Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 30, 2025, 10:00 AM EDT - 5 months ago

Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025, 5:00 PM EDT - 5 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect

May 29, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 29, 2025, 8:00 AM EDT - 5 months ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 5 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB ILMN NVS

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Schrödinger, Inc. (SDGR) And Encourages Stockholders to Reach Out

May 27, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Schrödinger, Inc. (SDGR) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Stockholders to Connect

May 26, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Stockholders to Connect

Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 25, 2025, 10:00 AM EDT - 5 months ago

Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Stockholders to Learn More About the Investigation

May 23, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Investors to Inquire about Securities Investigation

May 22, 2025, 12:00 PM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Investors to Inquire about Securities Investigation

Schrödinger to Present at Jefferies Global Healthcare Conference

May 22, 2025, 8:30 AM EDT - 5 months ago

Schrödinger to Present at Jefferies Global Healthcare Conference

Schrödinger: Regulatory Tailwinds Are Supportive Of Continued Strong Growth (Rating Upgrade)

May 20, 2025, 11:37 PM EDT - 5 months ago

Schrödinger: Regulatory Tailwinds Are Supportive Of Continued Strong Growth (Rating Upgrade)

Schrödinger Announces CFO Appointment

May 20, 2025, 6:30 AM EDT - 5 months ago

Schrödinger Announces CFO Appointment

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 14, 2025, 9:30 AM EDT - 5 months ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

Schrödinger, Inc. (SDGR) Q1 2025 Earnings Call Transcript

May 7, 2025, 5:59 PM EDT - 6 months ago

Schrödinger, Inc. (SDGR) Q1 2025 Earnings Call Transcript

Schrödinger Reports Strong First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 6 months ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

May 5, 2025, 8:30 AM EDT - 6 months ago

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

Apr 28, 2025, 8:00 AM EDT - 6 months ago

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

Apr 23, 2025, 8:30 AM EDT - 6 months ago

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Apr 14, 2025, 8:00 AM EDT - 7 months ago

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade)

Apr 12, 2025, 10:26 AM EDT - 7 months ago

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade)

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Mar 10, 2025, 8:30 AM EDT - 8 months ago

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Schrödinger: Still Waiting On A Catalyst

Mar 2, 2025, 1:24 AM EST - 8 months ago

Schrödinger: Still Waiting On A Catalyst

Schrödinger, Inc. (SDGR) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 7:27 PM EST - 8 months ago

Schrödinger, Inc. (SDGR) Q4 2024 Earnings Call Transcript

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Feb 26, 2025, 4:05 PM EST - 8 months ago

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Feb 24, 2025, 8:30 AM EST - 8 months ago

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Feb 12, 2025, 8:30 AM EST - 9 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

scott52
scott52 Oct. 24 at 2:48 PM
$SDGR $22.65. Sheer madness. Maybe a pump on some phase 1 bullshit and a chance to go dump the long and go short at $27.50.
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 21 at 7:05 PM
$SDGR POS
1 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 21 at 4:45 PM
$SDGR Buy the dip!
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 20 at 10:43 PM
$SDGR Going long for $30+
0 · Reply
VitaEBella
VitaEBella Oct. 20 at 9:22 PM
$SDGR Mamma Mia! I should leave town more often...
0 · Reply
OrzzrO
OrzzrO Oct. 20 at 5:07 PM
$SDGR keep pumping, what’s the story?
1 · Reply
xyzvector
xyzvector Oct. 19 at 3:51 PM
$SDGR AI potential and beaten down stock price....looks interesting
0 · Reply
luckydirb
luckydirb Oct. 19 at 3:31 AM
$SDGR as a deeply dei-ed company now, I don't see how they can grow up.
0 · Reply
SaluteYourShorts
SaluteYourShorts Oct. 15 at 1:47 PM
$SDGR heating up again
1 · Reply
stockwatcherking
stockwatcherking Oct. 15 at 1:34 PM
$SDGR Under the radar AI biotech ticker. Long here. I believe AI will transform the entire biotech industry, and SDGR will be a leader. Long here and $XBI
1 · Reply
SaluteYourShorts
SaluteYourShorts Oct. 13 at 7:26 PM
$SDGR blast from the past ... moving under radar
1 · Reply
lee305
lee305 Oct. 10 at 6:34 PM
$NKE $SDGR never a penny on a short in my life. Lol GL guys..
0 · Reply
jcooptechit
jcooptechit Oct. 9 at 5:15 PM
$HYFT MindWalk Ignites Investor Confidence with Share Buyback! MindWalk dropped a major catalyst this morning. Announcing a 2.3 million share repurchase program, representing roughly 5% of all outstanding shares. That’s a serious signal of confidence from management, and the market is reacting! Volume is surging today as bullish momentum builds around this news. 💡 Key Takeaways: ✅ 2.3M Share Buyback (5% of float) ✅ Strengthened Balance Sheet ✅ CEO & Board Signal Confidence ✅ High Volume Momentum Today CEO Jennifer Bath made it clear: the company believes the market has undervalued HYFT, and this buyback gives them the flexibility to capitalize when the stock trades below intrinsic value. Don’t sleep on HYFT as momentum is heating up fast! Big moves. Bigger conviction. Disclaimer: https://bit.ly/3KyS3C5 sector peers: $HYFT $BEAM $ABCL $SDGR
1 · Reply
Estimize
Estimize Oct. 9 at 11:03 AM
Wall St is expecting -0.71 EPS for $SDGR Q3 [Reporting 11/12 AMC] http://www.estimize.com/intro/sdgr?chart=historical&metric_name=eps&utm_c
0 · Reply
JarvisFlow
JarvisFlow Oct. 8 at 1:16 PM
Keybanc has updated their rating for Schrodinger ( $SDGR ) to Overweight with a price target of 28.
0 · Reply
gratefultobe
gratefultobe Oct. 6 at 9:54 PM
$SDGR this should be way way higher $40 to 50. Everything related to AI especially next which is how to leverage it in Healthcare (in this case drug discovery) got to explode. Some of these flat ones have been going up big. Look at i Intel, Unity, A few years ago IBM. Just a matter of time ...
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 7:48 AM
$SDGR: Unusual Options Activity Alerted CALL flow observed 300x contracts at Strike price of $30 Exp on 05/15/2026 with Premium of $50K and showing BULLISH Sentiment
0 · Reply
RunnerSignals
RunnerSignals Oct. 3 at 12:04 PM
$ASTL $AVXL $MRNA $OLED $SDGR making moves around key levels. from fresh lows to bullish reversals, momentum shifts are on watch https://stocksrunner.com/news/2025-10-03-daily-market-pulse-advanced-technical-analysis-and-trading-signals
0 · Reply
BB_88_
BB_88_ Oct. 1 at 8:19 PM
$SDGR wish I held my low 18s
0 · Reply
scott52
scott52 Oct. 1 at 7:15 PM
$SDGR They're buying some of the flea ridden losers today.
0 · Reply
KalliTRiTe
KalliTRiTe Oct. 1 at 5:10 PM
$SDGR Nice win. 😎
0 · Reply
erevnon
erevnon Sep. 30 at 2:37 PM
Goldman Sachs initiates coverage on Schrodinger $SDGR at Neutral rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply